CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative effect of adoption	Adjusted balance	Common Stock	Common Stock Restricted Stock Units	Common Stock Adjusted balance	Additional Paid-in Capital	Additional Paid-in Capital Adjusted balance	Retained Earnings	Retained Earnings Cumulative effect of adoption	Retained Earnings Adjusted balance	Treasury Stock	Treasury Stock Adjusted balance	Accumulated Other Comprehensive Income/(Loss)	Accumulated Other Comprehensive Income/(Loss) Adjusted balance	Non-controlling interest	Non-controlling interest Adjusted balance
Balance, beginning of period (in shares) at Dec. 31, 2019				55,188		55,188
Balance, beginning of period at Dec. 31, 2019	$ 1,596,145	$ 130	$ 1,596,275	$ 55		$ 55	$ 607,051	$ 607,051	$ 1,020,590	$ 130	$ 1,020,720	$ (177)	$ (177)	$ (31,374)	$ (31,374)	$ 0	$ 0
Balance, beginning of period (in shares) at Dec. 31, 2019												20	20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)					327
Equity withheld for employee taxes (in shares)					(106)
Equity withheld for employee taxes	(20,190)						(20,190)
Stock-based compensation expense	47,462						47,462
Exercise of stock options (in shares)				699
Exercise of stock options	26,449			$ 1			26,448
Other comprehensive income (loss)	5,862													5,862
Net income	327,160								327,160
Balance, end of period (in shares) at Dec. 31, 2020				56,108
Balance, end of period at Dec. 31, 2020	1,983,018			$ 56			660,771		1,347,880			$ (177)		(25,512)		0
Balance, end of period (in shares) at Dec. 31, 2020												20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)					311
Equity withheld for employee taxes (in shares)					(106)
Equity withheld for employee taxes	(45,070)						(45,070)
Stock-based compensation expense	69,899						69,899
Exercise of stock options (in shares)				536
Exercise of stock options	26,313			$ 1			26,312
Other comprehensive income (loss)	(28,695)													(28,695)
Noncontrolling interests acquired in business combination	10,469															10,469
Purchase of subsidiary shares from noncontrolling interest	(1,749)															(1,749)
Net income	$ 481,652								481,652
Balance, end of period (in shares) at Dec. 31, 2021	56,849			56,849
Balance, end of period at Dec. 31, 2021	$ 2,495,837			$ 57			711,912		1,829,532			$ (177)		(54,207)		8,720
Balance, end of period (in shares) at Dec. 31, 2021												20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)					252
Equity withheld for employee taxes (in shares)					(83)
Equity withheld for employee taxes	(23,650)						(23,650)
Stock issued in connection with Other 2021 acquisitions (Note 3) (in shares)				6								(6)
Stock issued in connection with Other 2021 acquisitions (Note 3)	2,000						1,941					$ 59
Stock-based compensation expense	107,513						107,513
Exercise of stock options (in shares)				511
Exercise of stock options	21,851			$ 1			21,850
Issuance of common stock from employee stock purchase plan (in shares)				120
Issuance of common stock from employee stock purchase plan	28,350						28,350
Other comprehensive income (loss)	(41,114)													(41,114)
Purchase of subsidiary shares from noncontrolling interest	(7,266)															(7,315)
Contributions from noncontrolling interest	73															73
Net income	$ 419,416								419,416
Balance, end of period (in shares) at Dec. 31, 2022	57,655			57,655
Balance, end of period at Dec. 31, 2022	$ 3,003,010			$ 58			$ 847,965		$ 2,248,948			$ (118)		$ (95,321)		$ 1,478
Balance, end of period (in shares) at Dec. 31, 2022												14